Carpen M E, Poplack D G, Pizzo P A, Balis F M
Pediatric Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
J Chromatogr. 1990 Mar 16;526(1):69-75. doi: 10.1016/s0378-4347(00)82484-6.
A paired-ion high-performance liquid chromatographic method was developed to measure concentrations of 2',3'-dideoxyinosine (ddI) in human plasma, urine and cerebrospinal fluid. Samples were prepared using a solid-phase extraction technique which allows for a five-fold concentration of the drug. 2'-Deoxyguanosine was added as an internal standard prior to the extraction. Recoveries for 2'-deoxyguanosine and ddI were 80 +/- 15 and 85 +/- 10%, respectively. Extracted samples were then injected onto a C18 column and eluted isocratically with a mobile phase containing 0.1% of the ion-pairing reagent, heptafluorobutyric acid, and 5% acetonitrile. The retention time was 7.4 min for 2'-deoxyguanosine and 8.4 min for ddI. The lower limit of detection for ddI is 0.1 microM. Using this technique the acid lability of ddI was demonstrated and the plasma concentration versus time profile from a patient receiving the drug was examined.
开发了一种配对离子高效液相色谱法,用于测定人血浆、尿液和脑脊液中2',3'-双脱氧肌苷(ddI)的浓度。使用固相萃取技术制备样品,该技术可使药物浓缩5倍。在萃取前加入2'-脱氧鸟苷作为内标。2'-脱氧鸟苷和ddI的回收率分别为80±15%和85±10%。然后将萃取后的样品注入C18柱,并用含有0.1%离子对试剂七氟丁酸和5%乙腈的流动相进行等度洗脱。2'-脱氧鸟苷的保留时间为7.4分钟,ddI的保留时间为8.4分钟。ddI的检测下限为0.1微摩尔。使用该技术证明了ddI的酸不稳定性,并检测了接受该药物治疗的患者的血浆浓度随时间的变化情况。